title: Acylcarnitine profile in thyroid disease.
abstract: OBJECTIVE
  To examine acylcarnitine profiles in individuals with hypo- or hyperthyroidism, and determine whether any atypical acylcarnitine species identified would normalize with correction of thyroid status.
  
  
  METHODS
  Serum acylcarnitine levels were measured in hypo- and hyperthyroid subjects before and after treatment with thyroxine or thionamide therapy respectively.
  
  
  RESULTS
  No discernible differences were observed in the serum acylcarnitine profiles between hypo-, hyper- and euthyroid states.
  
  
  CONCLUSIONS
  Acylcarnitine profiles are relatively unremarkable in thyroid disease.
authors.affiliation: Division of Medical Biochemistry, Department of Pathology and Laboratory Medicine, St. Paul's Hospital, Vancouver, Canada. Wong.Sophia@gmail.com
authors.forename: Sophia
authors.initials: S
authors.lastname: Wong
authors.forename: Fady
authors.initials: F
authors.lastname: Hannah-Shmouni
authors.forename: Graham
authors.initials: G
authors.lastname: Sinclair
authors.forename: Sandra
authors.initials: S
authors.lastname: Sirrs
authors.forename: Marshall
authors.initials: M
authors.lastname: Dahl
authors.forename: Andre
authors.initials: A
authors.lastname: Mattman
mesh_terms: D000328:Adult; D000368:Aged; D002331:Carnitine / Q000031:analogs & derivatives* / Q000097:blood; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood* / Q000188:drug therapy; D007037:Hypothyroidism / Q000097:blood* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012016:Reference Values; D013974:Thyroxine / Q000627:therapeutic use
chemical_list: C116917:acylcarnitine; D013974:Thyroxine; D002331:Carnitine